IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$13.6M
3
+$9.11M
4
SAGE
Sage Therapeutics
SAGE
+$6.18M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.32M

Top Sells

1
+$12.7M
2
+$11.7M
3
+$11.3M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.2M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
0
77
– –
-132,014
78
– –
-45,516
79
– –
0
80
– –
0
81
– –
-86,865
82
– –
-410
83
– –
-86,035
84
– –
-61,500
85
– –
-125,000
86
– –
0
87
– –
-100,000
88
– –
0
89
– –
-51,606
90
– –
-329
91
– –
-7,064
92
– –
-615,856
93
– –
0
94
– –
0
95
– –
0
96
– –
-105,341
97
– –
-70,277
98
– –
0
99
– –
-4,848
100
– –
0
2 3
4
5 6